Dr. Daniel D. Dulas, MD

Dr. Dulas practices at Mercy Hospital in Coon Rapids, Minnesota, part of Sutter Health.

Dr. Dulas' NPI, 1285672626, was assigned on June 4, 2006. Dr. Dulas graduated from University of Minnesota Medical School in 1986. Dr. Dulas holds Minnesota license 33752.

Dr. Dulas' primary practice is Mercy Hospital, at 4050 Coon Rapids Blvd, Coon Rapids, MN 55433 in Anoka County. The practice phone is (762) 236-6000.

Dr. Dulas' primary practice is Mercy Hospital in Coon Rapids, Minnesota, part of Sutter Health. Dr. Dulas is also affiliated with Buffalo Hospital. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Dulas to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dulas practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Dulas' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Dulas is licensed in Minnesota.

CMS data shows 659 Medicare services from Dr. Dulas across 16 procedure codes in 2024, for 384 Medicare patients. Medicare paid $39,763 for them.

CMS counts 384 Medicare patients who saw Dr. Dulas in 2024. The largest group is 75 to 84, with 152 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dulas' median patient age at 70, with 43% women.

In 2024, Dr. Dulas wrote 1,165 Medicare Part D claims for 286 patients. 95% of them were for generic drugs. CMS names the drug for 1,061 of them, across 19 drugs with 11 or more claims each, at $51,412 in total drug cost. In 2023, CMS named 986 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Dulas for performance year 2024, reported as part of a group. Dr. Dulas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 49 procedures of coronary angioplasty and stenting by Dr. Dulas, more than 83% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Dulas in 2020. Dr. Dulas' most frequent co-authors are Dinesh Arab, MD, Anvar Babaev, MD and Barry Dean Bertolet, MD.

Dmand AI links Dr. Dulas to 5 clinical trials. 2 are still active or recruiting. Conditions studied include Peripheral Arterial Disease, Peripheral Vascular Diseases and Atherosclerosis. C. R. Bard sponsors the most, 2. Open Payments lists research payments to Dr. Dulas that name 2 trials.

CMS Open Payments shows 131 general payments to Dr. Dulas from 24 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 48% of the total. Medtronic Vascular, Inc. paid the most, $14,580. It also lists 5 research payments totaling $1,840 in 2016, naming 2 clinical trials.

Dr. Dulas graduated from University of Minnesota Medical School in 1986.